Biotechnology Market Research Reports & Industry Analysis

Biotechnology, one of molecular biology’s branches, monitored and intentional manipulation of biological organisms, processes or systems to effectively make or process drugs, or any other products and substances useful to enhancing people’s living quality. The earliest examples of humans applying their knowledge of biotechnology involved the efforts to enhance plants and animals’ species by cross-pollination (allogamy) or cross-breeding.

Biotechnology has recently turned to a more sophisticated business, considerably enlarged in scale and application range. Having goodly restored from the recession, the world Biotechnology Market is anticipated to be eventually estimated at far over EUR 245 billion by end-2015. However, with the numerous benefits this advanced technology comes laden with, there are worries about its potential misuse. Concerns over this issue has trailed into some attempting to facilitate the enforcement of specific laws constraining or even banning relevant programs and research (e.g. human cloning).

The research reports from this Catalogue offer a comprehensive outlook on the worldwide Biotechnology Market. The reports identify major market challenging forces and growth drivers, provide fresh statistics on the Biotechnology Industry, outline various trends and factors specifying the market’s direction, and more. Regional and country markets’ reviews are at hand in the reports too. Furthermore, companies with their innovations are discussed, and also short to long term forecasts are provided in the researches.

Publications found: 1,808
Sort by:

The 2027-2032 World Outlook for DNA and RNA Sample Preparations

US$ 1,195.00

This study covers the world outlook for DNA and RNA sample preparations across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning...

January 2026 290 pages

The 2027-2032 World Outlook for DNA Polymerase

US$ 1,195.00

This study covers the world outlook for DNA polymerase across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...

January 2026 287 pages

The 2027-2032 World Outlook for DNA Read, Write and Edit Applications

US$ 1,195.00

This study covers the world outlook for DNA read, write and edit applications across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e...

January 2026 290 pages

The 2027-2032 World Outlook for DNA Sequencing

US$ 1,195.00

This study covers the world outlook for DNA sequencing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...

January 2026 287 pages

The 2027-2032 World Outlook for DNA Sequencing Diagnostics

US$ 1,195.00

This study covers the world outlook for DNA sequencing diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....

January 2026 288 pages

The 2027-2032 World Outlook for Gene Panels

US$ 1,195.00

This study covers the world outlook for gene panels across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...

January 2026 287 pages

The 2027-2032 World Outlook for Genetic Sequencing Tests

US$ 1,195.00

This study covers the world outlook for genetic sequencing tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....

January 2026 287 pages

The 2027-2032 World Outlook for Genome Sequencing

US$ 1,195.00

This study covers the world outlook for genome sequencing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...

January 2026 287 pages

The 2027-2032 World Outlook for Genomic Sequencing Technologies

US$ 1,195.00

This study covers the world outlook for genomic sequencing technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning...

January 2026 290 pages

The 2027-2032 World Outlook for Genomics Instruments and Systems

US$ 1,195.00

This study covers the world outlook for genomics instruments and systems across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnin...

January 2026 290 pages

The 2027-2032 World Outlook for Genomics and Proteomics Reagents, Research Kits and Analytical Instruments

US$ 1,195.00

This study covers the world outlook for genomics and proteomics reagents, research kits and analytical instruments across more than 190 countries. For each year reported, estimates are given for the l...

January 2026 307 pages

The 2027-2032 World Outlook for Genomics and Proteomics Sample Preparation Kits

US$ 1,195.00

This study covers the world outlook for genomics and proteomics sample preparation kits across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential...

January 2026 301 pages

The 2027-2032 World Outlook for Genomics and Proteomics Tools

US$ 1,195.00

This study covers the world outlook for genomics and proteomics tools across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings...

January 2026 288 pages

The 2027-2032 World Outlook for Genotyping Assays

US$ 1,195.00

This study covers the world outlook for genotyping assays across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...

January 2026 287 pages

The 2027-2032 World Outlook for Glass Bioactive Materials

US$ 1,195.00

This study covers the world outlook for glass bioactive materials across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...

January 2026 287 pages

The 2027-2032 World Outlook for Gold Nanoparticles Used in Healthcare

US$ 1,195.00

This study covers the world outlook for gold nanoparticles used in healthcare across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e...

January 2026 290 pages

The 2027-2032 World Outlook for Healthcare Nanotechnology and Nanomedicine Therapeutics

US$ 1,195.00

This study covers the world outlook for healthcare nanotechnology and nanomedicine therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or po...

January 2026 307 pages

The 2027-2032 World Outlook for Healthcare Nanotechnology (Nanomedicine)

US$ 1,195.00

This study covers the world outlook for healthcare nanotechnology (nanomedicine) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industr...

January 2026 293 pages

The 2027-2032 World Outlook for Hematopoietic Stem Cell Transplantation

US$ 1,195.00

This study covers the world outlook for hematopoietic stem cell transplantation across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry...

January 2026 291 pages

The 2027-2032 World Outlook for Human Embryonic Stem Cell (hESC) Regenerative Medicine Research

US$ 1,195.00

This study covers the world outlook for human embryonic stem cell (hESC) regenerative medicine research across more than 190 countries. For each year reported, estimates are given for the latent deman...

January 2026 307 pages

The 2027-2032 World Outlook for Human Embryonic Stem Cells

US$ 1,195.00

This study covers the world outlook for human embryonic stem cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....

January 2026 288 pages

The 2027-2032 World Outlook for Human Identification Consumables

US$ 1,195.00

This study covers the world outlook for human identification consumables across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnin...

January 2026 290 pages

The 2027-2032 World Outlook for In Situ Hybridization

US$ 1,195.00

This study covers the world outlook for in situ hybridization across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...

January 2026 287 pages

The 2027-2032 World Outlook for Induced Pluripotent

US$ 1,195.00

This study covers the world outlook for induced pluripotent across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...

January 2026 287 pages

The 2027-2032 World Outlook for Induced Pluripotent Stem Cell (iPSC)

US$ 1,195.00

This study covers the world outlook for induced pluripotent stem cell (iPSC) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ea...

January 2026 290 pages

The 2027-2032 World Outlook for Induced Pluripotent Stem Cells

US$ 1,195.00

This study covers the world outlook for induced pluripotent stem cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings...

January 2026 288 pages

The 2027-2032 World Outlook for Injectable Nanomedicines

US$ 1,195.00

This study covers the world outlook for injectable nanomedicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I....

January 2026 287 pages

The 2027-2032 World Outlook for Liver Organs-on-Chips

US$ 1,195.00

This study covers the world outlook for liver organs-on-chips across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...

January 2026 287 pages

The 2027-2032 World Outlook for Long Read Sequencing

US$ 1,195.00

This study covers the world outlook for long read sequencing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...

January 2026 287 pages

The 2027-2032 World Outlook for Longevity and Anti-Senescence Therapies

US$ 1,195.00

This study covers the world outlook for longevity and anti-senescence therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry...

January 2026 291 pages

The 2027-2032 World Outlook for Micro-Sized Hydroxyapatite

US$ 1,195.00

This study covers the world outlook for micro-sized hydroxyapatite across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....

January 2026 287 pages

The 2027-2032 World Outlook for Nano Healthcare Technology for Medical Equipment

US$ 1,195.00

This study covers the world outlook for nano healthcare technology for medical equipment across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential...

January 2026 303 pages

The 2027-2032 World Outlook for Nanomedicines

US$ 1,195.00

This study covers the world outlook for nanomedicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th...

January 2026 288 pages

The 2027-2032 World Outlook for NASH (Non-Alcoholic Steatohepatitis) Biomarkers

US$ 1,195.00

This study covers the world outlook for NASH (non-alcoholic steatohepatitis) biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential...

January 2026 299 pages

The 2027-2032 World Outlook for Native Collagen

US$ 1,195.00

This study covers the world outlook for native collagen across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...

January 2026 287 pages

The 2027-2032 World Outlook for Neurological Biomarkers

US$ 1,195.00

This study covers the world outlook for neurological biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...

January 2026 287 pages

The 2027-2032 World Outlook for Neurological Biomarkers for Alzheimers and Parkinsons Diseases

US$ 1,195.00

This study covers the world outlook for neurological biomarkers for Alzheimers and Parkinsons diseases across more than 190 countries. For each year reported, estimates are given for the latent demand...

January 2026 307 pages

The 2027-2032 World Outlook for Polymeric Biocompatible Materials

US$ 1,195.00

This study covers the world outlook for polymeric biocompatible materials across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earni...

January 2026 290 pages

The 2027-2032 World Outlook for Rare Biomarkers Specimen Collection and Stabilization

US$ 1,195.00

This study covers the world outlook for rare biomarkers specimen collection and stabilization across more than 190 countries. For each year reported, estimates are given for the latent demand, or pote...

January 2026 304 pages

The 2027-2032 World Outlook for Recombinant Non-Glycosylated Protein Biosimilars

US$ 1,195.00

This study covers the world outlook for recombinant non-glycosylated protein biosimilars across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential...

January 2026 301 pages

The 2027-2032 World Outlook for Regenerative Bone and Joint Medicines

US$ 1,195.00

This study covers the world outlook for regenerative bone and joint medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e...

January 2026 290 pages

The 2027-2032 World Outlook for Regenerative Medicine Cell Therapies

US$ 1,195.00

This study covers the world outlook for regenerative medicine cell therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ea...

January 2026 290 pages

The 2027-2032 World Outlook for Regenerative Medicines

US$ 1,195.00

This study covers the world outlook for regenerative medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....

January 2026 289 pages

The 2027-2032 World Outlook for Renal Biomarkers

US$ 1,195.00

This study covers the world outlook for renal biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...

January 2026 287 pages

The 2027-2032 World Outlook for RNA Analysis and Transcriptomics Microarrays

US$ 1,195.00

This study covers the world outlook for RNA analysis and transcriptomics microarrays across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential ind...

January 2026 294 pages

The 2027-2032 World Outlook for RNA-Based Therapeutics

US$ 1,195.00

This study covers the world outlook for RNA-based therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....

January 2026 287 pages

The 2027-2032 World Outlook for RNA-Based Therapeutics and Vaccines

US$ 1,195.00

This study covers the world outlook for RNA-based therapeutics and vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ear...

January 2026 290 pages

The 2027-2032 World Outlook for RNA Therapeutics

US$ 1,195.00

This study covers the world outlook for RNA therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...

January 2026 287 pages

The 2027-2032 World Outlook for RNAi Technologies

US$ 1,195.00

This study covers the world outlook for RNAi technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...

January 2026 287 pages

The 2027-2032 World Outlook for RNAi Therapeutics

US$ 1,195.00

This study covers the world outlook for RNAi therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...

January 2026 287 pages

Filters

Search

Categories

16
30
207
84
64
47
29
23
13
76
463
105
58
164
254
175

Publishers

20
1
19
65
68
314
148
12
13
338
51
50
1
52
185
6
1
1
9
2
2
4
141
2
1
5
1
24
2
10
2
1
1
4
8
1
3
1
1
3
1
59
4
5
6
3
25
3
3
11
2
2
11
31
25
24
20

Regions

2
2
1
4
1
15
11
19
1
11
9
10
1
14
1,707

Price

Date

Pages

Offers

4
2